ATE195151T1 - Verfahren zur bewertung von substanzen zum steigen bzw. zur modifizierung der apc-aktivität - Google Patents

Verfahren zur bewertung von substanzen zum steigen bzw. zur modifizierung der apc-aktivität

Info

Publication number
ATE195151T1
ATE195151T1 AT96117704T AT96117704T ATE195151T1 AT E195151 T1 ATE195151 T1 AT E195151T1 AT 96117704 T AT96117704 T AT 96117704T AT 96117704 T AT96117704 T AT 96117704T AT E195151 T1 ATE195151 T1 AT E195151T1
Authority
AT
Austria
Prior art keywords
modify
evaluation
substances
rise
apc activity
Prior art date
Application number
AT96117704T
Other languages
English (en)
Inventor
Jan Dr Rosing
Guido Dr Tans
Katalin Dr Varadi
Hans-Peter Doz Schwarz
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Ag filed Critical Baxter Ag
Application granted granted Critical
Publication of ATE195151T1 publication Critical patent/ATE195151T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96461—Protein C (3.4.21.69)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96463—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/04—Phospholipids, i.e. phosphoglycerides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96117704T 1995-11-09 1996-11-05 Verfahren zur bewertung von substanzen zum steigen bzw. zur modifizierung der apc-aktivität ATE195151T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/555,423 US5863896A (en) 1995-11-09 1995-11-09 Evaluation of substances for altering and for increasing APC response

Publications (1)

Publication Number Publication Date
ATE195151T1 true ATE195151T1 (de) 2000-08-15

Family

ID=24217207

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96117704T ATE195151T1 (de) 1995-11-09 1996-11-05 Verfahren zur bewertung von substanzen zum steigen bzw. zur modifizierung der apc-aktivität

Country Status (5)

Country Link
US (1) US5863896A (de)
EP (1) EP0776980B1 (de)
AT (1) ATE195151T1 (de)
DE (1) DE69609586T2 (de)
ES (1) ES2151118T3 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2159907C (en) * 1994-02-14 2006-12-12 Rogier Maria Bertina A method for screening for the presence of a genetic defect associated with thrombosis and/or poor anticoagulant response to activated protein c
US20070142272A1 (en) * 2003-01-24 2007-06-21 Zlokovic Berislav V Neuroprotective activity of activated protein c independent of its anticoagulant activity
WO2006014839A2 (en) * 2004-07-23 2006-02-09 The University Of Rochester Activated protein c inhibits undesirable effects of plasminogen activator in the brain

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
US5254532A (en) * 1989-06-26 1993-10-19 Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte Preparation for treating and preventing thromboses and thromboembolic complications, use of such a preparation and a method of producing the same
AT402262B (de) * 1991-06-20 1997-03-25 Immuno Ag Arzneimittel enthaltend aktiviertes protein c
EP0592600B1 (de) * 1991-07-02 2000-01-26 The Scripps Research Institute Protein-s polypeptide und deren verwendungen
JPH08506181A (ja) * 1993-01-29 1996-07-02 ダールベック，ビョルン 新規抗凝固性補助因子活性
EP0706564A1 (de) * 1993-06-30 1996-04-17 Rijksuniversiteit Leiden Protein s deletionsvarianten mit mangel an bindungsaktivitaet fuer c4bp, aber mit apc- cofaktor- aktivitaet, zusammensetzungen und therapeutische verfahren
EP0656424B1 (de) * 1993-12-03 2002-02-06 Baxter Aktiengesellschaft Test zur Bestimmung der Empfindlichkeit gegenüber aktiviertem Protein C
DE4418635C2 (de) * 1994-05-27 1997-07-24 Immuno Ag Pharmazeutische Zusammensetzung zur Vorbeugung und Behandlung von Blutgerinnungsstörungen

Also Published As

Publication number Publication date
EP0776980B1 (de) 2000-08-02
EP0776980A1 (de) 1997-06-04
DE69609586D1 (de) 2000-09-07
US5863896A (en) 1999-01-26
ES2151118T3 (es) 2000-12-16
DE69609586T2 (de) 2001-04-05

Similar Documents

Publication Publication Date Title
DE59405710D1 (de) Mittel zur rauchsimulation für streulichtrauchmelder, verfahren zum abgleich von deren rauchempfindlichkeit und verwendung des mittels
DE69511229D1 (de) Verfahren zur Analyse von gleichmässig erregten mechanischen Schwingungen
DE155247T1 (de) Verfahren zur mikrophotometrie von mikroskopischen prueflingen, apparat zur ausfuehrung dieses verfahrens.
DE69632447D1 (de) Analysator zur Analyse von Urinbestandteilen
DE59601159D1 (de) Verfahren zum gegenseitigen ausrichten von körpern und lagemesssonde hierfür
ATE193559T1 (de) Verfahren zur diagnose von schizophrenie
DE69019088D1 (de) Verfahren und Apparat zur Erneuerung einer Elektrode eines Biosensors.
ATE310955T1 (de) Zusammensetzungen und verfahren zum nachweis und zur behandlung von mit chemokinrezeptoren verbundenen krankheiten
DE69624406T2 (de) Verfahren zur Analyse von biologisch aktiven Substanzen
DE69325391T2 (de) Fotopolymerisierbare Zusammensetzung mit hoher Empfindlichkeit und dieseZusammensetzung verwendendes Vefahren zum Herstellen von Bildern
ATE315230T1 (de) Verfahren zum identifizieren von prostaglandin d2 rezeptor modulatoren
DE69827066D1 (de) Verfahren und Vorrichtung zum Kompensieren von Mehrkanalechos
DE60045613D1 (de) Verfahren zur optischen aufzeichnung von informationen, und vorrichtung zur optischen aufzeichnung von informationen durch dieses verfahren
DE59812896D1 (de) Vorrichtung zum optischen prüfen von oberflächen
DE69120359D1 (de) Verfahren zur identifizierung von candida albicans mittels chromogener substanzen
DE59602261D1 (de) Verfahren zum kompensieren des durch temperaturänderungen verursachten fehlverhaltens von messeinrichtungen
DE3764056D1 (de) Verfahren und vorrichtung zur aufzeichnung und/oder auswertung des bewegungsverhaltens von versuchstieren.
DE69511781T2 (de) Optisches Element für photolithographie und Verfahren zur Auswertung eines optischen Elements
DE69622978T2 (de) Analysator zur Analyse von Urinbestandteilen
ATE240406T1 (de) Neue testmethode, um den differenzierungszustand von bauchspeicheldrüsenzellen eines säugetieres festzustellen.
DE69535284D1 (de) Verfahren zur Präparation von Nukleinsäuren zur Analyse und Kits dafür
DE59610834D1 (de) Verfahren zur herstellung der vergleichbarkeit von spektrometermessungen
ATE195151T1 (de) Verfahren zur bewertung von substanzen zum steigen bzw. zur modifizierung der apc-aktivität
DE59010919D1 (de) N- und O-substituierte Aminophenolderivate, Zwischenprodukte zu deren Herstellung, deren Verwendung als Hydrolasesubstrate, ein entsprechendes Bestimmungsverfahren und hierfür geeignetes diagnostisches Mittel
DE69506099D1 (de) Verfahren zur prüfung des viskositatsanstiegs durch russ

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee